studying earliest stages alzheimer overt symptoms appear results reliable year food drug administration approved test called amyvid help evaluate patients memory deficits cognitive difficulties despite fda approval lingering doubts exact role amyloid alzheimer ambivalence practical value information provided scan fueled debate order amyvid test not excessive amyloid plaque develops alzheimer moment generally way predict unlucky ones recent studies shown roughly older citizens good mental health moderate high levels plaque noticeable ill effects raising specter disorder absence symptoms upset people helps effective treatments exist not new clinical trial investigate giving experimental drug soon scans detect formation plaques slow halt development alzheimer